NRSN
NeuroSense Therapeutics Ltd.stockNASDAQ
At CloseNov 17, 2026 10:58:56 AM EST
1.50USD-4.473%(-0.07)11,883
After-hoursNov 17, 2026 4:00:30 PM EST
1.51USD+1.003%(+0.01)
Loading…
Loading…
2.90M
Healthcare
Biotechnology
HQ
Herzliya, Israel
Previous Close
$1.57
Beta
1.50
52-Week High
$25.40 2025-11-19
52-Week Low
$1.10 2026-11-02
SMA 50
$3.97
SMA 200
$11.91
Avg. Vol 10D
31,492
Avg. Vol 30D
39,004
Avg. Vol 90D
27,633
Relative Vol
0.27
1.90M
1.19M
62.92%
27,182
2.28%
1.07
59%/41%
69.74%
37.39%
12.9700%
15,000
639
185
Sep 14, 2026 · 1-for-20 (reverse)
Nov 2, 2026
Oct 29, 2026
Oct 2, 2026
NeuroSense Provides Update on Nasdaq Listing Compliance ·
PR Newswire
Sep 28, 2026
NRSN Profile
advancing research, development and therapy for als. neurosense therapeutics is a biotech company focusing on the development of mirnas as a novel treatment for als. currently preparing for a first clinical study in patients in usa
NRSN Performance
| Period | Price | Date | Change | Beta |
|---|---|---|---|---|
| 1W | 1.98 | 2026-11-10 | -22.73% | -0.908 |
| 1M | 3.07 | 2026-10-16 | -50.16% | 1.820 |
| 3M | 8.64 | 2026-08-17 | -82.29% | 2.962 |
| 6M | 15.41 | 2026-05-18 | -90.07% | 2.303 |
| 1Y | 20.76 | 2025-11-17 | -92.63% | 1.498 |
| 2Y | 23.60 | 2024-11-18 | -93.52% | — |
| 5Y | 80.80 | 2021-12-09 | -98.11% | 0.713 |
NRSN Stock Summary
NeuroSense Therapeutics Ltd. (NASDAQ:NRSN) stock price today is $1.53, and today's volume is 10,533. NRSN is down 2.236% today. The 30 day average volume is 39,004. NRSN market cap is $2.90M with 1.90M shares outstanding.